best glp 1 for menopause weight loss GLP-1 in Menopause: How HRT Amplifies Results Women turn to weight loss

Importantly, a version of this compound called Vyleesi (bremelanotide injection) was approved by the FDA in 2019 for treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women

This compound is intended strictly for laboratory and scientific research purposes and is not approved for human or veterinary use

Diabetic retinopathy complications : For patients with diabetes and retinopathy, rapid improvement in glucose control with semaglutide may be associated with temporary worsening of retinopathy

Data availability The data analysed in the current study are available from the corresponding author on reasonable request

May 7 2024;21(2):182-194